Diaceutics have designed a series of core frameworks based on a technique called Case-based reasoning (CBR). Originated by the US Navy, CBR first appeared in commercial settings in the early 1990's and since then has been used in a wide number of applications both in academic and commercial fields. It is of particular use to decision makers when there is a wide body of relevant history which can be called on to determine both values for decision variables and define decision tree frameworks.
The Diaceutics CBR Model (Third Revision) currently relies on over 311 cases compiled from a combination of published and commissioned research. Collectively the model describes the ideal architecture of successful personalized medicine and theranostic programs.
The Diaceutics Model currently has a Patent Pending